Related Experiment Video
Updated: Jun 23, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric
Edward O Mason1, Linda B Lamberth, Wendy A Hammerman
1Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, and Infectious Disease Research Laboratory, Texas Children's Hospital, Houston, Texas 77030, USA. emason@bcm.edu
Abstract:
Vancomycin MICs for Staphylococcus aureus isolates in a pediatric hospital with a high rate of staphylococcal infections were examined for any increase over a 7-year period. A broth microdilution scheme allowed direct comparison of the MICs generated by this method to MICs generated by Etest. MICs generated by both methods were determined with the same inoculum suspension. One hundred sixty-five S. aureus isolates were selected on the basis of the patients having been bacteremic or having received vancomycin as the definitive therapy for their infections. Of the 165 isolates, 117 were methicillin-resistant S. aureus and 48 were methicillin-susceptible S. aureus. Forty-seven were acquired in the hospital (nosocomial), 56 were community acquired, and 62 were community onset-health care associated. All but one isolate tested by broth microdilution had MICs of < 1.0 microg/ml, while 96% of these same isolates tested by Etest had MICs of > or = 1 microg/ml. A significant increase in MICs that occurred after study year 4 (2004 to 2005) was demonstrated by the Etest (P < 0.00007) but not by broth microdilution. MICs were not different for isolates of community or health care origin, regardless of methodology. The proportion of isolates with Etest MICs of < 1 and > or = 1 microg/ml between children with bacteremia for < or = 5 days and > 5 days (P = 0.3) was not different. We conclude that MICs for pediatric isolates have increased slightly since 2005 and therapeutic decisions based on vancomycin MICs need to be made by considering the methodology used.
Insights
Vancomycin minimum inhibitory concentrations (MICs) for pediatric Staphylococcus aureus isolates show a slight increase since 2005. Therapeutic decisions require careful consideration of the testing methodology used for MIC determination.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Staphylococcus aureus infections are common in pediatric settings.
- Vancomycin is a critical antibiotic for treating resistant strains like methicillin-resistant S. aureus (MRSA).
- Monitoring vancomycin MIC trends is essential for effective treatment strategies.
Purpose of the Study:
- To investigate the trend of vancomycin minimum inhibitory concentrations (MICs) in pediatric Staphylococcus aureus isolates over a 7-year period.
- To compare MICs determined by broth microdilution and Etest methods.
- To assess the impact of infection source and duration of bacteremia on vancomycin MICs.
Main Methods:
- Analysis of 165 Staphylococcus aureus isolates from pediatric patients over 7 years.
- Comparison of vancomycin MICs using broth microdilution and Etest.
- Categorization of isolates by resistance (MRSA/MSSA), acquisition (nosocomial, community-acquired, healthcare-associated), and bacteremia duration.
Main Results:
- Broth microdilution showed most isolates had MICs < 1.0 µg/ml, while Etest indicated 96% had MICs ≥ 1 µg/ml.
- Etest detected a significant increase in vancomycin MICs after study year 4 (2004-2005), but broth microdilution did not.
- No significant difference in MICs was observed based on isolate origin or duration of bacteremia.
Conclusions:
- Vancomycin MICs in pediatric S. aureus isolates have slightly increased since 2005.
- Discrepancies between broth microdilution and Etest highlight the importance of methodology in interpreting MIC values.
- Clinical decisions regarding vancomycin therapy must account for the specific MIC testing method employed.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Automated Microbial Diagnostics
Mechanism of Antibiotic Resistance in MRSA
Estimation of k and VD of Aminoglycosides
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism